Derivation of Huntington Disease affected Genea018 human embryonic stem cell line

Stem Cell Res. 2016 Mar;16(2):423-6. doi: 10.1016/j.scr.2016.02.006. Epub 2016 Feb 3.

Abstract

The Genea018 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, carrying Htt gene CAG expansion of 46 repeats, indicative of Huntington Disease. Following ICM outgrowth on inactivated human feeders, karyotype was confirmed as 46, XX by CGH and STR analysis demonstrated a female Allele pattern. The hESC line had pluripotent cell morphology, 75% of cells expressed Nanog, 91% Oct4, 73% Tra1-60 and 96% SSEA4, gave a Pluritest pluripotency score of 31.12, Novelty of 1.45, demonstrated Alkaline Phosphatase activity and tri-lineage teratoma formation. The cell line was negative for Mycoplasma and visible contamination.

MeSH terms

  • Animals
  • Blastocyst / cytology*
  • Cells, Cultured
  • Cellular Reprogramming
  • Comparative Genomic Hybridization
  • Female
  • Flow Cytometry
  • Human Embryonic Stem Cells / cytology*
  • Human Embryonic Stem Cells / metabolism
  • Human Embryonic Stem Cells / transplantation
  • Humans
  • Huntington Disease / genetics
  • Huntington Disease / metabolism
  • Huntington Disease / pathology*
  • Karyotype
  • Mice
  • Microsatellite Repeats / genetics
  • Microscopy, Fluorescence
  • Teratoma / metabolism
  • Teratoma / pathology
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transplantation, Heterologous

Substances

  • Transcription Factors